Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HM7G
|
|||
| Former ID |
DIB004580
|
|||
| Drug Name |
SUVN-G1031
|
|||
| Synonyms |
Histamine-3 antagonists (metabolic disorders/neurodegenerative diseases); Histamine-3 antagonists (metabolic disorders/neurodegenerative diseases), Suven
Click to Show/Hide
|
|||
| Indication | Metabolic disorder [ICD-11: 5C50-5D2Z; ICD-10: E70-E90; ICD-9: 270-279] | Investigative | [1] | |
| Company |
Suven Life Sciences Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Antagonist | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 264). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.